1. Home
  2. CGEM vs UPWK Comparison

CGEM vs UPWK Comparison

Compare CGEM & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$22.73

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Upwork Inc.

UPWK

Upwork Inc.

N/A

Current Price

$8.53

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CGEM
UPWK
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
CGEM
UPWK
Price
$22.73
$8.53
Analyst Decision
Strong Buy
Buy
Analyst Count
8
11
Target Price
$30.13
$22.73
AVG Volume (30 Days)
667.6K
3.9M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.44
Revenue
N/A
$787,784,000.00
Revenue This Year
N/A
$9.06
Revenue Next Year
$5.20
$13.57
P/E Ratio
N/A
$19.48
Revenue Growth
N/A
2.40
52 Week Low
$5.68
$7.44
52 Week High
$22.54
$22.84

Technical Indicators

Market Signals
Indicator
CGEM
UPWK
Relative Strength Index (RSI) 70.66 42.81
Support Level $16.40 $7.71
Resistance Level N/A $9.61
Average True Range (ATR) 1.16 0.39
MACD 0.27 -0.06
Stochastic Oscillator 92.97 26.06

Price Performance

Historical Comparison
CGEM
UPWK

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

About UPWK Upwork Inc.

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.

Share on Social Networks: